Introduction
Simple febrile seizures (SFSs) are the most common type of seizure during childhood. The peak incidence is at the age of approximately 18 months, occurring in 2-5% of all children. 1 Because of their association with later epilepsy, many independent risk factors (genetic factors, age, gender, fever, type and duration of seizure, family and developmental history, multiple seizures, perinatal exposure to antiretroviral drugs, history of maternal smoking and alcohol consumption during pregnancy) have been studied as potential predictors of recurrent febrile seizures. [2] [3] [4] [5] However, the data available in the literature are inconsistent. [6] [7] [8] [9] Iron plays a critical role in the metabolism of several neurotransmitters, and in low iron status, aldehyde oxidases and monoamine are reduced. In addition, the expression of cytochrome C oxidase, a marker of neuronal metabolic activity, is decreased in iron deficiency. 10 In developing countries, iron deficiency is one of the most prevalent nutritional problems, 11 especially among infants aged between 6 and 24 months. [12] [13] [14] [15] [16] In developing countries 46-66% of all children under 4 years of age are anemic, with half of the prevalence attributed to irondeficiency anemia. Many studies have clearly demonstrated the effect of iron on development, cognition, behavior and neurophysiology, and especially on brain metabolism, neurotransmitter function and myelination. 17 Iron-deficiency anemia is common during the second and third years of life and has been variably associated with developmental and behavioral impairments, hence it can influence motor and cognitive skills. 10, 11 Because iron is important for the function of various enzymes and neurotransmitters in the central nervous system, low serum levels of ferritin may lower the seizure threshold. 18, 19 We compared iron status in children with febrile seizures and a control group in order to determine the relationship between iron status and febrile seizures in pediatric patients in southern Iran.
Patients and methods
The study group consisted of 300 children with a first febrile seizure admitted to the pediatric emergency departments of Shiraz University of Medical Sciences, Shiraz, southern Iran, between March 2007 and January 2009. Written informed consent was obtained from the parents of all patients for inclusion in the study, which was approved by the Shiraz University of Medical Sciences Ethics Committee. Simple febrile seizures were defined as seizure occurring between the ages of 6 months and 5 years, associated with a rectal temperature of at least 38.3 8C or an axillary temperature of at least 37.8 8C documented either in the emergency department or in the medical record, <15 min duration, without evidence of central nervous system infection, focal neurological signs or history of seizure, and occurring once in the previous 24 h. The seizure was defined as complex if it lasted >15 min, occurred more than once in 24 h or had focal features. Children with developmental delay, definite neurological illness, or a history of proved iron-deficiency anemia, regular blood transfusion or regular therapeutic doses of iron supplements were excluded. A control group (n = 200) was selected randomly from children admitted for febrile illnesses such as gastroenteritis, otitis media or respiratory tract infections without seizure, previous history of seizure or anticonvulsant therapy. Case and control groups were comparable for age, gender, normal growth and development, family history of febrile seizures, temperature at presentation, white blood cell count and differential, and use of iron supplementation. Age, sex, underlying illness, frequency and duration of seizures were recorded for both groups. Because ferritin is an acute-phase reactant protein in inflammatory and infectious processes, serum ferritin (SF) concentration was measured by ELISA and double-checked 72 h after the onset of the febrile illness. Anemia was defined as a decrease in mean hemoglobin (Hb) level below 2 standard deviations of the normal values for age, i.e. Hb < 10.5 g/dl for ages 6-24 months and <11.5 g/dl for ages 2-5 years. Hemoglobin, mean corpuscular volume (MCV), and SF concentration were compared in the case and control groups.
Statistical analysis
The data were analyzed with the SPSS version 15 software package for Windows (Chicago, IL, USA) by two-sample t-test. Pearson's chi-squared test was used to calculate the differences in proportions. Discrete variables are expressed as counts and percentages. P values < 0.05 were considered significant.
Results
Our results were based on 300 children with SFS (158 boys, 142 girls) and a control group of 200 children (72 boys, 128 girls). Table  1 shows the mean values of Hb, MCV and SF in case and control groups. For this study we divided the sample into two age subgroups of 6 months to 2 years (Table 2 ) and 2-5 years (Table 3 ).
The proportion of children with Hb < 10.5 g/dl was higher in both control subgroups (P = 0.0001, Tables 2 and 3 ). Serum ferritin concentration was significantly lower in both case subgroups (57.5% vs. 22% and 55.7% vs. 27.6%, P = 0.0001). The differences in MCV were not significant in either age subgroup. In children aged 6 months to 2 years (Table 2 ) and 2-5 years (Table 3) , SF was significantly lower (P = 0.0001) in the SFS group.
In both age subgroups, the use of nontherapeutic doses of iron supplements was more frequent in children with febrile illness without seizure than in the case group with SFS (Tables 2 and 3 ).
Discussion
This study showed that patients with febrile seizures were more frequently iron deficient as defined by below-normal SF levels. There is controversy regarding the role of iron status in febrile convulsions, which are considered a benign seizure syndrome distinct from epilepsy. 1 Previous studies have reported a relationship between iron-deficiency anemia and convulsions in patients with malaria. 19 In addition, iron-deficiency anemia can cause developmental delay and behavioral disturbances early in life, and correcting anemia early may reverse these processes. [20] [21] [22] Naveed and Billo showed that SF levels were significantly lower in children with febrile seizure compared to controls, and suggested that children with iron deficiency are more prone to febrile seizures. 23 Another study found that the incidence of febrile seizures in patients with thalassemia was much lower than among children in the general population. 24 Thus, iron overload may be a major factor in the brain metabolism that prevents febrile seizures. Kobrinsky et al. also suggested that iron-deficiency anemia raises the threshold for febrile seizure, 19 whereas Daoud et al. showed
that SF levels were significantly lower in patients with a first febrile seizure than in patients with febrile illness without convulsions. 18 Pisacane et al. reported an association between iron-deficiency anemia and febrile convulsions in Neapolitan children. 2 In Table 3 Characteristics of cases and controls at ages 2-5 years. contrast, Momen and Hakimzadeh reported no relationship between iron-deficiency anemia and first febrile convulsion in children younger than 5 years of age in Iran. 25 In another study in Iran, Bidabadi and Mashouf reported that iron-deficiency anemia was less frequent among patients with febrile seizure than in controls, and found no protective effect of iron deficiency against febrile convulsions. 26 Pisacane et al., in their comparative study of age-and sex-matched children, reported a significantly higher rate of iron-deficiency anemia, defined on the basis of low serum iron concentration, among children with febrile seizure than in the control group. 2 In children younger than 2 years of age, 30% of those with febrile seizures had anemia compared to 14% in the control group. However, SF levels were not measured in that study.
In the present study the difference in MCV between the case and control group overall and between children aged 6 months to 2 years with and without SFS was not significant, but it was significant in the 2-to-5 year old age group. Kobrinsky et al. also reported that patients with febrile seizures were less frequently iron deficient as defined by elevated free erythrocyte protoporphyrin, but in their study, SF levels were not measured. 19 Of the indices of body iron status measured in the present study, SF level was the only value that was significantly lower in children with SFS than in the control group -a finding also reported by Daoud et al. 18 Although fever was present in all of our patients in both groups, SF levels were measured 72 h after the onset of the febrile illness. None of the patients in either group were being treated for iron-deficiency anemia on presentation, but significant numbers of patients in both groups sometimes used non-therapeutic doses of iron supplements. We did not evaluate the response to iron therapy in children in whom febrile seizures recurred. Our results suggest that low SF levels may play a role in febrile seizures.
Limitations
The main limitation of this study was the potential confounding effect of ferritin as an acute-phase reactant agent, which can interfere with the influence of iron status on febrile seizures. This limitation could be overcome by predicting the time when ferritin level returned to its baseline value after the acute-phase reaction.
Conclusion
Low body iron status may decrease the threshold of seizure and be a risk factor for the development of febrile seizures.
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